PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.34%
Positive revenue growth while EXP is negative. John Neff might see a notable competitive edge here.
-70.43%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-91.94%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-91.94%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
1.19%
Positive net income growth while EXP is negative. John Neff might see a big relative performance advantage.
1.61%
Positive EPS growth while EXP is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1.64%
Positive diluted EPS growth while EXP is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.11%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.14%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
336.67%
10Y revenue/share CAGR 1.25-1.5x EXP's 256.37%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
172.59%
5Y revenue/share CAGR above 1.5x EXP's 83.42%. David Dodd would look for consistent product or market expansions fueling outperformance.
91.43%
3Y revenue/share CAGR above 1.5x EXP's 52.48%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
527.76%
Net income/share CAGR above 1.5x EXP's 175.93% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
372.68%
5Y net income/share CAGR above 1.5x EXP's 155.91%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
170.55%
3Y net income/share CAGR above 1.5x EXP's 36.45%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
118.86%
5Y equity/share CAGR above 1.5x EXP's 9.21%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.95%
3Y equity/share CAGR above 1.5x EXP's 9.55%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.